OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7481$2403.0056

Oie Sangyo Co Ltd

Food Retail & DistributionVerified

Oie Sangyo Co Ltd maintains a strong liquidity position, with a current ratio of 1.2 and cash and equivalents amounting to ¥3.99 billion, which supports its short-term obligations. The company's low debt-to-equity ratio of 0.03 indicates a conservative capital structure, with minimal reliance on long-term debt. Profitability metrics show a healthy balance, with a tangible book value of ¥12.69 billion and a price-to-book ratio of 1.57, suggesting the company is valued in line with its tangible assets. The operating cash flow of ¥2.81 billion supports ongoing operations and reinvestment. The company's revenue is primarily concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification. This concentration may expose the company to regional economic fluctuations, though the lack of disclosed geographic breakdown limits further analysis. Growth trajectory appears stable, with the most recent actual revenue reported at ¥119.26 billion. While no forward-looking revenue growth rates are provided, the company's consistent operating cash flow and low debt suggest a stable financial foundation. Risk factors are minimal, with low liquidity and dilution risk identified. No immediate filing-based liquidity or dilution flags were detected, and the company's capital structure remains stable with no dilution potential in the near term. Recent events include the latest actual EPS of ¥339.57 and revenue of ¥119.26 billion, as reported in the most recent financial filings. No significant new developments or regulatory changes have been disclosed in the latest available data.

30-day price · 7481-267.00 (-10.2%)
Low$2238.00High$2659.00Close$2359.00As of12 May, 00:00 UTC
Profile
CompanyOie Sangyo Co Ltd
Ticker7481.T
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Oie Sangyo Co Ltd operates in the Food & Drug Retailing sector, primarily generating revenue through the retail and distribution of food and drug products.

Classification. Oie Sangyo Co Ltd is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.

Oie Sangyo Co Ltd maintains a strong liquidity position, with a current ratio of 1.2 and cash and equivalents amounting to ¥3.99 billion, which supports its short-term obligations. The company's low debt-to-equity ratio of 0.03 indicates a conservative capital structure, with minimal reliance on long-term debt. Profitability metrics show a healthy balance, with a tangible book value of ¥12.69 billion and a price-to-book ratio of 1.57, suggesting the company is valued in line with its tangible assets. The operating cash flow of ¥2.81 billion supports ongoing operations and reinvestment. The company's revenue is primarily concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification. This concentration may expose the company to regional economic fluctuations, though the lack of disclosed geographic breakdown limits further analysis. Growth trajectory appears stable, with the most recent actual revenue reported at ¥119.26 billion. While no forward-looking revenue growth rates are provided, the company's consistent operating cash flow and low debt suggest a stable financial foundation. Risk factors are minimal, with low liquidity and dilution risk identified. No immediate filing-based liquidity or dilution flags were detected, and the company's capital structure remains stable with no dilution potential in the near term. Recent events include the latest actual EPS of ¥339.57 and revenue of ¥119.26 billion, as reported in the most recent financial filings. No significant new developments or regulatory changes have been disclosed in the latest available data.
Key takeaways
  • Oie Sangyo Co Ltd maintains a conservative capital structure with low debt and strong liquidity.
  • The company's valuation is in line with its tangible book value, indicating a stable market perception.
  • Revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification.
  • Growth appears stable, supported by consistent operating cash flow and low financial leverage.
  • No immediate liquidity or dilution risks are present, and the company's risk profile is favorable.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$2.81B
CapEx-$137.8M
Free cash flow
Total assets$35.41B
Total liabilities$22.72B
Total equity$12.69B
Cash & equivalents$3.99B
Long-term debt$426.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$66.14B-$2.67B-$2.99B-$2.68B
FY-3$70.60B-$748.4M-$114.1M$301.9M
FY-2$94.83B$1.69B$1.63B$2.08B
FY-1$111.38B$3.24B$3.06B$3.05B
FY0$119.26B$3.56B$2.81B$2.00B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$26.81B$9.90B$2.93B
FY-3$27.44B$9.52B$3.21B
FY-2$33.01B$11.04B$4.08B
FY-1$35.41B$12.69B$3.99B
FY0$37.60B$14.48B$6.13B
PeriodOCFCapExFCFSBC
FY-4-$1.85B-$416.5M-$2.68B
FY-3$520.1M-$260.6M$301.9M
FY-2$2.58B-$45.9M$2.08B
FY-1$2.81B-$137.8M$3.05B
FY0$3.74B-$525.0M$2.00B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$28.51B$885.0M$791.0M
FQ-5$29.81B$1.05B$724.0M
FQ-4$32.54B$800.0M$553.0M
FQ-3$28.39B$821.0M$745.0M
FQ-2$31.66B$925.0M$666.0M
FQ-1$32.77B$1.06B$745.0M
FQ0$34.42B$968.0M$660.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$35.41B$12.69B$3.99B
FQ-6$33.87B$12.82B$3.28B
FQ-5$36.55B$13.56B$5.86B
FQ-4$40.45B$13.78B$4.55B
FQ-3$37.60B$14.48B$6.13B
FQ-2$37.43B$14.66B$6.12B
FQ-1$40.08B$15.49B$7.14B
FQ0$43.53B$15.80B$6.31B
PeriodOCFCapExFCFSBC
FQ-7$2.81B-$137.8M
FQ-6
FQ-5$2.88B-$522.0M
FQ-4
FQ-3$3.74B-$525.0M
FQ-2
FQ-1$2.09B-$26.0M
FQ0
Valuation
Market price$2403.00
Market cap$19.95B
Enterprise value$16.38B
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF5.8
P/B1.6
P/Tangible book1.6
Tangible book$12.69B
Net cash$3.56B
Current ratio1.2
Debt/Equity0.0
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
Metric7481Activity
Op margin3.1% medp25 1.2% · p75 6.8%
Net margin2.0% medp25 0.7% · p75 4.1%
Gross margin26.1% medp25 17.2% · p75 32.0%
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity3.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Observations
IR observations
Last actual EPS339.57 JPY
Last actual revenue119,256,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:48 UTC#b5a24735
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 03:02 UTCJob: fa1db639